Most Dangerous Medication Interactions
Based on the available medical evidence, several categories of drug-drug interactions (DDIs) pose significant clinical risks. According to available evidence, drug-drug interactions are a major cause of preventable adverse drug events [1].
High-Risk Interaction Categories
Antimicrobial Interactions in Critical Care
In intensive care settings, antimicrobials frequently cause dangerous interactions [2]:
- Linezolid interactions are particularly concerning:
- Linezolid + dopamine/metoclopramide → hypertension [2]
- Linezolid + dopamine/dobutamine → hypertension [2]
- Antifungal interactions:
- Voriconazole + budesonide → increased serum concentration of budesonide [2]
- Quinolone interactions:
- Levofloxacin + amiodarone → QT prolongation [2]
RAAS Blocker Interactions
ACE inhibitors and ARBs have several dangerous interactions [3]:
- Hyperkalemia risk is enhanced when RAAS blockers are combined with:
- Potassium-sparing diuretics
- Potassium supplements
- Trimethoprim
- Beta-blockers
- Antifungal agents
- Calcineurin inhibitors
- NSAIDs
- Heparins [3]
- Angioedema risk increases with ACE inhibitors combined with:
- mTOR inhibitors
- DPP4 inhibitors
- Alteplase
- Sacubitril/valsartan [3]
Oral Anticancer Drug Interactions
Cancer medications have multiple dangerous interaction pathways [4]:
- CYP3A4 inhibitors and inducers can significantly alter drug levels
- Gastric acid suppression interactions affect drug absorption
- QT interval prolongation interactions increase cardiac arrhythmia risk
- Anticoagulant interactions increase bleeding risk [4]
Opioid Interactions
Oxycodone interactions are particularly common in cancer patients [5]:
- 89.4% of oxycodone treatment episodes contained at least one pharmacologically relevant DDI perpetrator
- 82.7% were considered clinically relevant [5]
- Multiple CYP3A4 and CYP2D6 perpetrators can cause "double interactions" [5]
Clinical Significance
According to available evidence, 2.87% of potential drug-drug interactions in ICU patients were classified as actual DDIs [2], indicating that while many interactions are theoretically possible, a smaller percentage result in clinically observable effects.
The sources do not provide comprehensive information about all dangerous medication interactions, particularly those involving common outpatient medications, cardiovascular drugs beyond RAAS blockers, or psychiatric medications.